Related Experiment Video
Updated: Aug 9, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Left ventricular dysfunction and arrhythmias in asymptomatic patients with systemic sclerosis
Lilian López Núñez1, Irene Carrión-Barberà1, Luis Molina2
1Rheumatology Department, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain.
Insights
Systemic sclerosis (SS) patients often have silent cardiac issues. Global longitudinal strain (GLS) detected more left ventricular systolic dysfunction (LVSD) in SS, suggesting early cardiac involvement.
Area of Science:
- Cardiology
- Rheumatology
- Internal Medicine
Background:
- Cardiac involvement in systemic sclerosis (SS) is a significant cause of mortality, often presenting asymptomatically.
- Early detection of cardiac dysfunction and arrhythmias is crucial for managing SS patients.
Purpose of the Study:
- To investigate the prevalence and associations of left ventricular dysfunction (LVD) and arrhythmias in asymptomatic SS patients without cardiovascular risk factors.
- To evaluate the utility of global longitudinal strain (GLS) and cardiac biomarkers in detecting cardiac abnormalities in SS.
Main Methods:
- A prospective study included 36 SS patients without cardiac symptoms or risk factors.
- Evaluations included clinical assessment, blood tests (NT-proBNP, troponin T), electrocardiogram (EKG), Holter monitoring, and echocardiography with GLS.
- Arrhythmias were classified as clinically significant (CSA) or non-significant.
Main Results:
- Left ventricular diastolic dysfunction (LVDD) was present in 28%, LV systolic dysfunction (LVSD) by GLS in 22%, and cardiac dysautonomia in 16.7%.
- EKG and Holter revealed alterations in 50% and 55.6% of patients, respectively, with 44% and 75% of these being CSA.
- Elevated troponin T (TnTc) correlated with CSA, while elevated NT-proBNP and TnTc correlated with LVDD.
Conclusions:
- Global longitudinal strain (GLS) identified a higher prevalence of LVSD in SS patients compared to ejection fraction (LVEF), highlighting its importance in routine evaluation.
- Cardiac biomarkers NT-proBNP and TnTc may serve as minimally invasive markers for LVDD in SS.
- The lack of correlation between LVD and CSA suggests arrhythmias may stem from early, independent cardiac involvement, warranting active investigation in all SS patients.
Introduction And Aims:
Cardiac involvement in systemic sclerosis (SS) is frequently silent and a major cause of mortality in these patients. This work aims to study the prevalence and associations of left ventricular dysfunction (LVD) and arrhythmias in SS.
Methods And Results:
Prospective study of SS patients (n=36), excluding those with symptoms of (or) cardiac disease, pulmonary arterial hypertension or cardiovascular risk factors (CVRF). A clinical, analytical, electrocardiogram (EKG), Holter, and echocardiogram with global longitudinal strain (GLS) assessment were performed. Arrhythmias were classified into clinically significant arrhythmias (CSA) and non-significant. Twenty-eight percent had left ventricular diastolic dysfunction (LVDD), 22% LV systolic dysfunction (LVSD) according to the GLS, 11.1% both, and 16.7% cardiac dysautonomia. Fifty percent presented alterations by EKG (44% CSA), 55.6% by Holter (75% CSA) and 8.3% CSA by both. An association was found between the elevation of troponin T (TnTc) and CSA and between the elevation of both NT-proBNP and TnTc with LVDD.
Conclusions:
We found a higher prevalence of LVSD than in the literature, detected by GLS and being 10 times higher than that detected by LVEF, which justifies the need to incorporate this technique in the routine evaluation of these patients. The association of TnTc and NT-proBNP with LVDD suggests that they can be used as minimally invasive biomarkers of this affectation. The absence of correlation between LVD and CSA indicates that the arrhythmias could be due, not only to a supposed structural alteration of the myocardium, but to an independent and early cardiac involvement, which should be actively investigated even in asymptomatic patients without CVRF.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
07:11Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy I: Introduction and Classification